More Business Wire
View Older Stories View Newer Stories-
PharmaEssentia to Present Early-Stage Pipeline Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, Highlighting Immuno-Oncology Approaches for Solid Tumors
-
Parameter Technologies Announces Agreement to Be Acquired by Acuity Inc. as Part of Distech Controls™
-
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
-
Bank of Marin Bancorp Reports Third Quarter Financial Results Driven by Loan Growth, NIM Expansion and Higher Earnings
-
Audi and Universal Display Celebrate 10 Years of OLED Technology in Audi Production Vehicles
-
Empery Digital Resumes Share Repurchases and Provides Update on Capital Allocation Priorities and Midwest Data Center Investment
-
Boston Omaha Corporation Completes Sale of its Surety Insurance Business Unit to CopperPoint Insurance Company
-
XTEND Reports Preliminary Third Quarter 2026 Results, Names Former Navy SEAL Captain Matt McGraw U.S. CEO, and Issues Letter to Shareholders
-
Intrepid Selected for USDA Matching Grant Award to Support Carlsbad Sulfate of Potash Project
-
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Digimarc Returns from RGCA with Strong Market Interest in Its Next-Generation Gift Card Security
-
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
-
ACMC Partners with AI Resource Intelligence Company Scepter to Evaluate Critical Minerals Projects
-
Herc Holdings Inc. Announces CEO Succession Plan
-
Paradium.AI to Host Third Quarter 2026 Financial Results Conference Call on Monday, November 9, 2026
-
MasterBrand Announces CFO Transition
-
Delcath Systems to Host Third Quarter 2026 Earnings Call
-
ORAFOL Fresnel Optics Cuts Inspection Times in Half with Zebra Technologies’ AI Machine Vision Solution
-
Dubai Culture Opens Registration for ISEA2026 Dubai
-
Medifast Announces Third Quarter 2026 Financial Results
-
Ameresco Completes $5.9M Advanced Metering Infrastructure Project for the City of Mustang, Oklahoma
-
Sierra Bancorp Reports Record Quarterly Income
-
Town Lane Raises $1.9 Billion for Second Real Estate Investment Fund
-
Object First Earns Dual Honors for Innovation in Data Security and Ransomware Protection
-
Acelot to Present on TDP-43 Targeting in ALS at 2026 NEALS Meeting
-
Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans
-
Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026
-
Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School
-
Genesys Earns 2026 Great Place to Work Certification Across 23 Countries
-
Second Front Achieves U.S. Department of Veterans Affairs Authorization to Operate
-
Shionogi to Present New Real-World Data Advancing the Understanding of ALS at the 2026 Annual NEALS Meeting
-
Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approach
-
Stem Announces Review of Strategic Alternatives to Maximize Shareholder Value
-
Hadron Energy Strengthens Halo Reactor Engineering Team with Three Senior Component Design and Analysis Leaders
-
Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers
-
DT Research Unveils LT365PA Rugged Laptop Bringing NVIDIA Graphics and AI Processing to Mission-Critical Field Teams
-
Corcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer
-
Coincheck Group N.V. to Announce Second Quarter 2027 Financial Results on November 9, 2026
-
VantageScore CreditGauge™ September 2026: Overall Balances Hold Steady as Consumer Credit Remains Stable
-
Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Breakthrough Therapy Designation for Treatment of R/R KMT2A-Rearranged Acute Leukemia
-
Walmart Expands Better Care Services, Powered by General Medicine’s Healthcare Store
-
Archer To Report Third Quarter 2026 Operating Update and Financial Results on November 9th, 2026
-
L Catterton Announces Strategic Investment in Glance
-
o9 Solutions Named a Leader in Analyst Evaluation of Supply Chain Platforms, Q3 2026
-
Dynex Capital, Inc. Named One of TIME’s America’s Growth Leaders for 2027
-
CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
-
Westwin Elements Appoints David Kronenfeld as Chief Legal Officer
-
Cyera Earns FedRAMP® High (Class D) Certified Status, Clearing the Way for Federal Agencies to Safely Adopt Agentic AI
-
Mubadala Capital Announces Strategic Investment from Apollo
-
Solid Power Announces Significant Advancement in Commercial Pathway, Commissioning MOBIUS™ Continuous Electrolyte Manufacturing Line
